Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | G6PD | P11413 | 1/20 | 0.49 |
| ▸ | PYGB | P11216 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13576889 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL14421703 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL136446 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL166332 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL14898436 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL50473 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL12632768 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL21847893 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL20745165 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR | |
| SCHEMBL10307315 | 1.00 | L3MBTL1 (0.56) | L3MBTL1MAPTLGALS8GAATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-10-05 | — | — | US | disclosed |
| US-20170183557-A1 | ALKYL POLYGLYCOSIDE DERIVATIVE AS BIODEGRADABLE FOAMING SURFACTANT FOR CEMENT | HALLIBURTON ENERGY SERVICES, INC. | 2017-06-29 | — | — | US | disclosed |
| US-20160324826-A1 | METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | HAWKING BIOLOGICAL TECHNOLOGY CO., LTD. (TW) | 2016-11-10 | — | — | US | disclosed |
| US-9370529-B2 | Tannin inhibitors of HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2016-06-21 | — | — | US | disclosed |
| US-9370529-B2 | Tannin inhibitors of HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2016-06-21 | — | — | US | disclosed |
| US-20160038520-A1 | TANNIN INHIBITORS OF HIV | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-02-11 | — | — | US | disclosed |
| US-20160038520-A1 | TANNIN INHIBITORS OF HIV | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-02-11 | — | — | US | disclosed |
| US-20160002565-A1 | TRICRESYL PHOSPHATE-FREE OIL, LUBRICANT OR TURBINE OIL | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2016-01-07 | — | — | US | disclosed |
| US-9181291-B2 | Tannin inhibitors of HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-9181291-B2 | Tannin inhibitors of HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-20140248230-A1 | HAIR CARE TREATMENT AGENT | HENKEL AG & CO. KGAA (DE) | 2014-09-04 | — | — | US | disclosed |
| US-20140248229-A1 | NOURISHING HAIR TREATMENT COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2014-09-04 | — | — | US | disclosed |
| US-20140045765-A1 | METHOD FOR INHIBITING AUTOPHAGY OF MOTOR NEURONS | CHINA MEDICAL UNIVERSITY (TW) | 2014-02-13 | — | — | US | disclosed |
| US-20130252909-A1 | TANNIN INHIBITORS OF HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130252909-A1 | TANNIN INHIBITORS OF HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2013-09-26 | — | — | US | disclosed |
| WO-2013008062-A1 | NON COVALENT MOLECULAR STRUCTURE, COMPRISING A PYRENE BASED GLYCOCONJUGATE, DEVICE COMPRISING THE SAME AND ITS USE FOR DETECTION OF LECTIN | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2013-01-17 | — | — | WO | disclosed |
| US-20110224414-A1 | USE OF 9, 10-ANTHRAQUINONE COMPOUNDS | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2011-09-15 | — | — | US | disclosed |
| US-20100216727-A1 | Carbohydrate-metallocene-antimalarial conjugates | ADVANCED APPLIED PHYSICS SOLUTIONS (CA) | 2010-08-26 | — | — | US | disclosed |
| US-7572604-B2 | Modified carbohydrate processing enzyme | ISIS INNOVATION LIMITED (GB) | 2009-08-11 | — | — | US | disclosed |
| US-20090181444-A1 | MODIFIED CARBOHYDRATE PROCESSING ENZYME | ISIS INNOVATION LIMITED (GB) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160324826-A1 | METHOD FOR PROVIDING AN INCREASED EXPRESSION OF TELOMERASE, BRAIN-DERIVED NEUROTROPHIC FACTOR, STROMAL CELL-DERIVED FACTOR-1, CXC CHEMOKINE RECEPTOR 4, AND/OR IMMUNE REGULATORY FACTOR OF STEM CELL | CXCL12, CXCR4, BDNF | L3MBTL1 2791/4885MAPT 1484/4885LGALS8 1193/4885 |
| US-20110224414-A1 | USE OF 9, 10-ANTHRAQUINONE COMPOUNDS | HCCS, CYC1, C1S | L3MBTL1 2429/4885MAPT 4858/4885LGALS8 4283/4885 |
| US-20140248229-A1 | NOURISHING HAIR TREATMENT COMPOSITION | NOTUM, PNISR, INCENP | L3MBTL1 2377/4885MAPT 2126/4885LGALS8 4380/4885 |
| US-20100216727-A1 | Carbohydrate-metallocene-antimalarial conjugates | G6PD, SLC40A1, SLC2A8 | L3MBTL1 946/4885MAPT 2941/4885LGALS8 97/4885 |
| US-20130252909-A1 | TANNIN INHIBITORS OF HIV | SERPINB1, TSN, FURIN | L3MBTL1 3830/4885MAPT 328/4885LGALS8 510/4885 |
| US-20140045765-A1 | METHOD FOR INHIBITING AUTOPHAGY OF MOTOR NEURONS | ATG7, BECN1, SQSTM1 | L3MBTL1 1669/4885MAPT 247/4885LGALS8 4003/4885 |
| US-20140248230-A1 | HAIR CARE TREATMENT AGENT | H1-4, H1-0, H1-10 | L3MBTL1 2948/4885MAPT 2619/4885LGALS8 2673/4885 |
| US-20160038520-A1 | TANNIN INHIBITORS OF HIV | SERPINB1, TSN, FURIN | L3MBTL1 3830/4885MAPT 328/4885LGALS8 510/4885 |
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | FOLH1, CD44, SLC10A1 | L3MBTL1 1068/4885MAPT 1100/4885LGALS8 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.